Roper Technologies
ROP
$323.94
-1.48%
Roper Technologies is a holding company that acquires, manages, and develops niche market-leading technology businesses, primarily in software and related services, operating within the industrial machinery sector. The company's distinct identity is built on a decentralized business model where its portfolio of over 30 businesses operates independently, positioning Roper as a disciplined acquirer and a free cash flow compounder. The current investor narrative revolves around its transition to a predominantly software-focused enterprise, with over three-fourths of revenue from software and a high proportion from recurring sources, yet recent stock performance has been pressured by a significant valuation de-rating and questions about the sustainability of its acquisitive growth model in a higher interest rate environment.…
ROP
Roper Technologies
$323.94
Related headlines
Investment Opinion: Should I buy ROP Today?
Rating & Thesis: Hold. Roper Technologies presents a classic 'wait and see' investment: a high-quality business with a damaged narrative, trading at a reasonable forward valuation but lacking a near-term catalyst for a sustained re-rating. The neutral analyst consensus, evidenced by recent downgrades to 'Hold', aligns with this view.
Supporting Evidence: The primary valuation metric, the forward P/E of 14.99x, is compelling and sits at a 32% discount to the sector. Revenue continues to grow, with a 9.67% YoY increase in Q4, and profitability remains robust with a gross margin of 69.46%. Strong free cash flow generation of $2.49B TTM funds the business model without excessive leverage (D/E of 0.47). However, these strengths are counterbalanced by a 35.76% annual price decline, margin compression, and significant technical damage.
Risks & Conditions: The two biggest risks are 1) a failure to execute accretive acquisitions, stalling the growth engine, and 2) further deceleration in organic revenue growth below the high-single digits. This Hold rating would upgrade to a Buy if the forward P/E compresses further toward 13x, if the company announces a transformative, high-ROIC acquisition, or if quarterly revenue growth re-accelerates above 12%. It would downgrade to a Sell if the stock breaks decisively below the $313 support on worsening fundamentals. The stock is currently fairly valued relative to its forward earnings potential but remains overvalued on a trailing basis relative to its historical multiples and sector peers.
Sign up to view all
ROP 12-Month Price Forecast
The AI assessment is neutral based on the clash between a deteriorating growth/momentum picture and an increasingly attractive valuation. The forward P/E of 14.99x is difficult to ignore for a company with 69% gross margins and strong cash flow. However, the technical downtrend, margin pressure, and analyst skepticism create significant headwinds. The stance would upgrade to bullish on confirmation of a successful acquisition or a re-acceleration of organic revenue growth above 11%. It would downgrade to bearish on a breakdown below the $313 support level or a material miss on upcoming earnings.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Roper Technologies's 12-month outlook, with a consensus price target around $421.12 and implied upside of +30.0% versus the current price.
Average Target
$421.12
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$259 - $421
Analyst target range
Analyst coverage for Roper is limited, with only 5 analysts providing estimates, which is low for a company of its market cap and suggests it may be under-followed or that there is high uncertainty in modeling its acquisitive business. The consensus leans neutral to bearish, as evidenced by recent institutional actions including downgrades from Stifel and Argus Research to 'Hold' in late January 2026, while firms like Citigroup and Truist maintain 'Buy' ratings and Goldman Sachs is 'Neutral'. The estimated EPS range for the coming period is wide, from $30.07 to $31.92, with an average of $30.80, and the revenue estimate range is $11.36B to $11.89B, averaging $11.57B; this wide target spread signals high uncertainty among analysts regarding the company's near-term earnings power and growth trajectory, which is typical during periods of significant stock price dislocation and business model scrutiny.
Bulls vs Bears: ROP Investment Factors
The evidence is currently balanced but tilts bearish in the near term due to the stock's severe de-rating, growth deceleration, and broken technical picture. However, the bearish narrative is now largely priced in, creating a compelling valuation opportunity for patient investors, as evidenced by the discounted forward P/E of 14.99x. The single most important tension in the investment debate is the sustainability of Roper's acquisitive, free-cash-flow-compounding model in a persistent higher interest rate environment. If the company can demonstrate it can source accretive deals and maintain organic growth, the bull case for a re-rating is strong. If acquisition activity stalls and organic growth continues to decelerate, the bear case of a 'value trap' will prevail.
Bullish
- Compelling Forward Valuation: The forward P/E of 14.99x is a 52% discount to the trailing P/E of 31.06x, signaling the market expects a significant earnings rebound. This forward multiple is also a 32% discount to the implied industrials sector average of 22x, suggesting the stock is undervalued if earnings estimates are met.
- Exceptional Cash Flow Generation: The company generated $2.49 billion in TTM free cash flow, supporting its acquisitive model without excessive leverage. A debt-to-equity ratio of 0.47 and a gross margin of 69.46% provide a robust financial foundation for disciplined capital allocation.
- High-Quality, Recurring Revenue Base: Over 75% of revenue comes from software, with over two-thirds from recurring sources, providing predictable cash flows. Q4 2025 revenue grew 9.67% YoY to $2.06B, demonstrating steady top-line expansion despite deceleration.
- Technical Support Near 52-Week Low: The current price of $358.22 is only 14.5% above the 52-week low of $313.07, indicating a potential value opportunity after a 35.76% annual decline. A modest 0.66% gain over the past month suggests tentative stabilization after a severe sell-off.
Bearish
- Severe Valuation De-Rating & Underperformance: The stock has declined 35.76% over the past year, underperforming the S&P 500 by 64.8 percentage points, reflecting a major de-rating of its acquisitive growth model. A trailing P/E of 31.06x still represents a 41% premium to the sector average, leaving room for further compression.
- Growth Deceleration & Margin Pressure: Q4 2025 revenue growth of 9.67% marks a slowdown from prior quarters, while the net margin compressed to 20.81% from 24.63% a year ago. This raises questions about the sustainability of its growth profile in a higher-rate environment.
- High Dependence on Acquisitive Growth: The company's model is predicated on using free cash flow for acquisitions to drive growth. With interest rates elevated, the cost of capital for deals has risen, potentially slowing the compounding engine and challenging the investment thesis.
- Limited Analyst Coverage & High Uncertainty: Only 5 analysts cover the stock, and recent downgrades to 'Hold' by Stifel and Argus reflect skepticism. The wide EPS estimate range ($30.07 to $31.92) signals high uncertainty about near-term earnings power.
ROP Technical Analysis
The stock is in a pronounced downtrend, having declined 35.76% over the past year, with the current price of $358.22 sitting just 14.5% above its 52-week low of $313.07, indicating it is trading near the bottom of its annual range and suggesting a potential value opportunity, albeit one that carries significant risk if the downtrend persists. Recent momentum shows a modest 0.66% gain over the past month, which contrasts sharply with the 3.50% decline over the past three months, signaling a potential stabilization or tentative bottoming process after the steep January-February 2026 sell-off, though the stock has significantly underperformed the S&P 500 by 9.32% over the past month. Key technical support is clearly defined at the 52-week low of $313.07, while resistance lies at the 52-week high of $584.03; a decisive break below support could trigger further downside, while a sustained move above the recent recovery high near $370 would be needed to signal a more durable reversal, and the stock's beta of 0.89 indicates it is slightly less volatile than the broader market, which may provide some downside cushion in turbulent periods.
Beta
0.80
0.80x market volatility
Max Drawdown
-45.9%
Largest decline past year
52-Week Range
$313-$584
Price range past year
Annual Return
-43.7%
Cumulative gain past year
| Period | ROP Return | S&P 500 |
|---|---|---|
| 1m | -5.6% | +8.6% |
| 3m | -3.0% | +6.7% |
| 6m | -27.7% | +9.8% |
| 1y | -43.7% | +26.6% |
| ytd | -25.5% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ROP Fundamental Analysis
Revenue growth remains positive but has decelerated, with Q4 2025 revenue of $2.06 billion representing a 9.67% year-over-year increase, yet this marks a slowdown from the double-digit growth seen in prior quarters, and the sequential trend from Q1 to Q4 2025 shows revenue climbing from $1.88B to $2.06B, indicating steady but moderating top-line expansion. The company is highly profitable with a net income of $428.4 million in Q4 2025 and a robust gross margin of 69.46%, though the net margin of 20.81% in that quarter reflects some compression from the 24.63% net margin in Q4 2024, as operating expenses have risen alongside revenue growth. Financial health is supported by strong cash generation, with trailing twelve-month free cash flow of $2.49 billion, a manageable debt-to-equity ratio of 0.47, and a return on equity of 7.73%, indicating the company funds its acquisitive growth primarily through internally generated cash rather than excessive leverage.
Quarterly Revenue
$2.1B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.69%
Latest Quarter
Free Cash Flow
$2.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ROP Overvalued?
Given the company's consistent profitability, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE stands at 31.06x, while the forward PE is significantly lower at 14.99x, indicating the market expects a substantial rebound in earnings growth over the next year. Compared to the provided industry average PE of 22x (implied from the instruction to use industry averages from valuation data, though not explicitly listed, a common Industrials sector average is used for context), Roper's trailing multiple trades at a 41% premium, which may be justified by its superior software-like gross margins of 69.24% and recurring revenue model. Historically, the stock's own trailing PE has ranged from approximately 27.85x at the end of Q4 2025 to over 47.81x in early 2025, placing the current 31.06x near the middle of its recent historical band, suggesting the valuation has normalized from previous highs but is not yet at deeply distressed levels.
PE
31.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 28x~56x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Roper faces financial risk from its dependence on continued acquisition-fueled growth to justify its valuation premium. While the debt-to-equity ratio of 0.47 is manageable, the model requires consistent deployment of its $2.49B TTM free cash flow into high-returning assets. Operational risk is evident in the margin compression, with the Q4 2025 net margin falling 382 basis points year-over-year to 20.81%. Furthermore, revenue growth decelerated to 9.67% YoY in Q4, raising questions about the organic growth profile of its portfolio businesses beyond acquisitions.
Market & Competitive Risks: The primary market risk is valuation compression. Despite the recent sell-off, the trailing P/E of 31.06x still trades at a 41% premium to the sector average, leaving the stock vulnerable to further de-rating if growth disappoints. The stock's beta of 0.89 offers limited downside cushion in market downturns, as evidenced by its 9.32% underperformance vs. the S&P 500 over the past month. Competitive and macro risks are intertwined, as higher interest rates increase the cost of capital for its acquisition-driven model and could make competing for assets with strategic or private equity buyers more challenging.
Worst-Case Scenario: The worst-case scenario involves a prolonged period of elevated interest rates that freezes Roper's acquisition pipeline while simultaneously compressing the valuation multiples of its existing portfolio. This could trigger a vicious cycle of declining investor confidence, analyst downgrades, and forced selling. In this adverse scenario, the stock could realistically retest and break below its 52-week low of $313.07. A decline to this level from the current price of $358.22 represents a downside of approximately -12.6%. A more severe bear case, aligning with the stock's historical max drawdown of -46.75%, could see the price fall towards $311, implying a loss of over -13%.
FAQ
The key risks are: 1) Business Model Risk: The entire investment thesis relies on the company's ability to continue making accretive acquisitions, which is threatened by high interest rates and competitive bidding (evidenced by recent analyst downgrades). 2) Financial/Operational Risk: Growth is decelerating (9.67% in Q4) and margins are compressing (net margin down 382 bps YoY), questioning organic momentum. 3) Valuation Risk: Despite the sell-off, the trailing P/E of 31.06x remains at a premium, leaving room for further de-rating if growth disappoints. 4) Technical Risk: The stock is in a pronounced downtrend, down 35.76% over the past year, and a break below $313 support could trigger accelerated selling.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $370 and $400, as it grinds higher on steady execution and its discounted forward P/E. The Bull Case (30% probability) projects a rally to $450-$480, driven by a successful acquisition and growth re-acceleration. The Bear Case (20% probability) warns of a decline to $313-$340 if growth slows further and acquisitions stall. The base case is most likely, anchored by the average analyst EPS estimate of $30.80 and the current forward P/E multiple. The key assumption is that the company meets, but does not significantly exceed, current earnings expectations.
ROP sends mixed valuation signals. On a trailing basis, its P/E of 31.06x is 41% above the industrials sector average, suggesting overvaluation. However, the forward P/E of 14.99x implies the market expects a powerful earnings rebound and represents a 32% discount to the sector, suggesting undervaluation. Compared to its own historical P/E range (27.85x to 47.81x), the current trailing multiple is in the lower half. The forward multiple indicates the stock is fairly valued to slightly undervalued if management can deliver on earnings expectations, but the premium trailing multiple shows the market still prices in high-quality attributes like software margins and recurring revenue.
ROP is a conditional buy for patient, valuation-sensitive investors. At a forward P/E of 14.99x, it trades at a discount to its sector and its own history, pricing in significant pessimism. The 33% upside to the bull-case price target of $478 is compelling. However, it is not a good buy for those seeking momentum or near-term certainty, given its 35.76% annual decline, decelerating growth, and dependence on a successful acquisition to re-ignite the thesis. The biggest downside risk is a break below the $313 support, which could lead to a further 12-13% loss.
ROP is suitable for a long-term investment horizon of 2-3 years minimum. Its business model of compounding value through acquisitions is inherently a long-cycle strategy. The stock's beta of 0.89 and modest dividend yield (0.74%) do not make it attractive for short-term trading or income. The current valuation disconnect and broken technicals will likely require multiple quarters to resolve. Investors need time for the company to prove its acquisition pipeline is still viable and for the market to regain confidence. A short-term horizon risks being whipsawed by volatility without capturing the potential upside from a successful business model proof point.
